4.5 Article

Puerarin Ameliorates 5-Fluorouracil-Induced Intestinal Mucositis in Mice by Inhibiting JAKs

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, Research & Experimental

Prophylactic and therapeutic supplementation using fructo-oligosaccharide improves the intestinal homeostasis after mucositis induced by 5-fluorouracil

Paula Lopes Armond Carvalho et al.

Summary: Prebiotic fructo-oligosaccharides (FOS) have beneficial effects in preventing and treating intestinal mucositis, with total treatment with FOS being more effective than pre-treatment alone.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Chemistry, Medicinal

Puerarin inhibits the development of osteoarthritis through antiinflammatory and antimatrix-degrading pathways in osteoarthritis-induced rat model

Tian-wen Ma et al.

Summary: The study showed that puerarin has anti-inflammatory and anti-matrix-degrading effects in a rat osteoarthritis model, reducing cartilage damage, inhibiting inflammatory factors, and promoting cartilage repair.

PHYTOTHERAPY RESEARCH (2021)

Article Gastroenterology & Hepatology

Efficacy of JAK inhibitors in Crohn's Disease

Gerhard Rogler

JOURNAL OF CROHNS & COLITIS (2020)

Article Medicine, Research & Experimental

Puerarin inhibits inflammation and oxidative stress in dextran sulfate sodium-induced colitis mice model

Yong-Deok Jeon et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Article Biotechnology & Applied Microbiology

TAK-242 ameliorates DSS-induced colitis by regulating the gut microbiota and the JAK2/STAT3 signaling pathway

Jiajia Wang et al.

MICROBIAL CELL FACTORIES (2020)

Article Gastroenterology & Hepatology

Differential biomechanical properties of mouse distal colon and rectum innervated by the splanchnic and pelvic afferents

Saeed Siri et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2019)

Article Gastroenterology & Hepatology

JAK selectivity for inflammatory bowel disease treatment: does it clinically matter?

Silvio Danese et al.

Article Pharmacology & Pharmacy

Anti-colorectal cancer biotargets and biological mechanisms of puerarin: Study of molecular networks

Jun Li et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2019)

Article Medicine, Research & Experimental

Qingjie Fuzheng Granule attenuates 5-fluorouracil-induced intestinal mucosal damage

Ling Zhang et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Article Pharmacology & Pharmacy

Colon-specific microspheres loaded with puerarin reduce tumorigenesis and metastasis in colitis-associated colorectal cancer

Xiao-Qing Deng et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)

Review Chemistry, Medicinal

Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Recent Data

Fumi Varyani et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2019)

Article Immunology

JAK Inhibitors and Oxidative Stress Control

Amandine Charras et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Pharmacology & Pharmacy

Absolute oral bioavailability and disposition kinetics of puerarin in female rats

Tosapol Anukunwithaya et al.

BMC PHARMACOLOGY & TOXICOLOGY (2018)

Article Cell Biology

Effect of puerarin on transcriptome of astrocyte during oxygen-glucose deprivation/reoxygenation injury

Shuyong Wei et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)

Article Integrative & Complementary Medicine

Garidisan: Improving the Quality of Ulcer Healing in Rats with Ulcerative Colitis

Lin Wang et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)

Article Multidisciplinary Sciences

Mucus organisation is shaped by colonic content; a new view

J. B. J. Kamphuis et al.

SCIENTIFIC REPORTS (2017)

Article Biochemistry & Molecular Biology

Virtual screening and synthesis of quinazolines as novel JAK2 inhibitors

Su Hui Yang et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

Tyrphostin-like compounds with ubiquitin modulatory activity as possible therapeutic agents for multiple myeloma

Zhenghong Peng et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth

Zhe Li et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)